Global Gynecology Drugs Market, By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2027
The global gynecology drugs market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the global gynecology drugs market in the forecast period.
The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the global gynecology drugs market in the forecast period.
The global gynecology drugs market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.
Major companies operating in the global gynecology market are Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth and the market size of the global gynecology drugs market from 2017 to 2021.
- To estimate and forecast the market size of the global gynecology drugs market from 2023 to 2027 and growth rate until 2027.
- To classify and forecast the global gynecology drugs market is divided into therapeutics, indication, distribution channel, regional distribution, and competitive landscape.
- To identify drivers and challenges for the global gynecology drugs market.
- To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global gynecology drugs market.
- To conduct pricing analysis for the global gynecology drugs market.
- To identify and analyze the profile of leading players operating in global gynecology drugs market.
TechSci Research calculated the global gynecology drugs market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Gynecology drugs manufacturers/ suppliers/ distributors
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to gynecology drugs
- Market research and consulting firms
Report Scope:
In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Gynecology Drugs Market, By Therapeutics:
- Non-Hormonal Therapy
- Hormonal Therapy
- Gynecology Drugs Market, By Indication:
- Contraception
- Gynecology Infections
- Female Infertility
- Postmenopausal disorders
- Polycystic Ovary Syndrome
- Osteoporosis
- Gynecology Cancers
- Endometriosis
- Others (Urogenital Malformation, UTI & others)
- Gynecology Drugs Market, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Gynecology Drugs Market, By Region:
- North America
Canada
Mexico
- Europe
France
United Kingdom
Italy
Spain
- Asia-Pacific
Japan
India
Australia
South Korea
- South America
Argentina
Colombia
- Middle East & Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1.Eli Lilly and Company Ltd.
2.Pfizer Inc.
3.Merck & Co., Inc.
4.Amgen Inc.
5.AstraZeneca Plc
6.F. Hoffmann-La Roche Ltd.
7.Allergan Plc.
8.Bayer AG
9.Abbott Laboratories Ltd.
10.AbbVie Inc.
11.GlaxoSmithKline Plc
12.Novartis Ltd.
13.Lupin Pharmaceuticals, Inc.
14.Johnson and Johnson Inc.
15.Sanofi SA
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Voice of Customer
- 4.1. Brand Awareness
- 4.2. Factors Affecting Purchase Decision
- 4.3. Product Preference, By Therapeutics
- 5. Impact of COVID-19 on Global Gynecology Drugs Market
- 6. Global Gynecology Drugs Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)
- 6.2.2. By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others)
- 6.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)
- 6.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
- 6.2.5. By Company (2021)
- 6.3. Product Market Map
- 7. North America Gynecology Drugs Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Therapeutics
- 7.2.2. By Indication
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Gynecology Drugs Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Therapeutics
- 7.3.1.2.2. By Indication
- 7.3.1.2.3. By Distribution Channel
- 7.3.2. Canada Gynecology Drugs Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Therapeutics
- 7.3.2.2.2. By Indication
- 7.3.2.2.3. By Distribution Channel
- 7.3.3. Mexico Gynecology Drugs Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Therapeutics
- 7.3.3.2.2. By Indication
- 7.3.3.2.3. By Distribution Channel
- 8. Europe Gynecology Drugs Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Therapeutics
- 8.2.2. By Indication
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. Germany Gynecology Drugs Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Therapeutics
- 8.3.1.2.2. By Indication
- 8.3.1.2.3. By Distribution Channel
- 8.3.2. France Gynecology Drugs Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Therapeutics
- 8.3.2.2.2. By Indication
- 8.3.2.2.3. By Distribution Channel
- 8.3.3. United Kingdom Gynecology Drugs Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Therapeutics
- 8.3.3.2.2. By Indication
- 8.3.3.2.3. By Distribution Channel
- 8.3.4. Italy Gynecology Drugs Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Therapeutics
- 8.3.4.2.2. By Indication
- 8.3.4.2.3. By Distribution Channel
- 8.3.5. Spain Gynecology Drugs Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Therapeutics
- 8.3.5.2.2. By Indication
- 8.3.5.2.3. By Distribution Channel
- 9. Asia Pacific Gynecology Drugs Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Therapeutics
- 9.2.2. By Indication
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
- 9.3. Asia Pacific: Country Analysis
- 9.3.1. China Gynecology Drugs Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Therapeutics
- 9.3.1.2.2. By Indication
- 9.3.1.2.3. By Distribution Channel
- 9.3.2. Japan Gynecology Drugs Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Therapeutics
- 9.3.2.2.2. By Indication
- 9.3.2.2.3. By Distribution Channel
- 9.3.3. India Gynecology Drugs Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Therapeutics
- 9.3.3.2.2. By Indication
- 9.3.3.2.3. By Distribution Channel
- 9.3.4. Australia Gynecology Drugs Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Therapeutics
- 9.3.4.2.2. By Indication
- 9.3.4.2.3. By Distribution Channel
- 9.3.5. South Korea Gynecology Drugs Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Therapeutics
- 9.3.5.2.2. By Indication
- 9.3.5.2.3. By Distribution Channel
- 10. South America Gynecology Drugs Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Therapeutics
- 10.2.2. By Indication
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Gynecology Drugs Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Therapeutics
- 10.3.1.2.2. By Indication
- 10.3.1.2.3. By Distribution Channel
- 10.3.2. Argentina Gynecology Drugs Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Therapeutics
- 10.3.2.2.2. By Indication
- 10.3.2.2.3. By Distribution Channel
- 10.3.3. Colombia Gynecology Drugs Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Therapeutics
- 10.3.3.2.2. By Indication
- 10.3.3.2.3. By Distribution Channel
- 11. Middle East and Africa Gynecology Drugs Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Therapeutics
- 11.2.2. By Indication
- 11.2.3. By Distribution Channel
- 11.2.4. By Country
- 11.3. Middle East and Africa: Country Analysis
- 11.3.1. South Africa Gynecology Drugs Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Therapeutics
- 11.3.1.2.2. By Indication
- 11.3.1.2.3. By Distribution Channel
- 11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Therapeutics
- 11.3.2.2.2. By Indication
- 11.3.2.2.3. By Distribution Channel
- 11.3.3. UAE Gynecology Drugs Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Therapeutics
- 11.3.3.2.2. By Indication
- 11.3.3.2.3. By Distribution Channel
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends and Developments
- 14. Competitive Landscape
- 14.1. Company profiles
- 14.1.1. Eli Lilly and Company Ltd.
- 14.1.2. Pfizer Inc.
- 14.1.3. Merck & Co., Inc.
- 14.1.4. Amgen Inc.
- 14.1.5. AstraZeneca Plc
- 14.1.6. F. Hoffmann-La Roche Ltd.
- 14.1.7. Allergan Plc.
- 14.1.8. Bayer AG
- 14.1.9. Abbott Laboratories Ltd.
- 14.1.10. AbbVie Inc.
- 14.1.11. GlaxoSmithKline Plc
- 14.1.12. Novartis Ltd.
- 14.1.13. Lupin Pharmaceuticals, Inc.
- 14.1.14. Johnson and Johnson Inc.
- 14.1.15. Sanofi SA
- 15. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook